Cargando…
Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer Health
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791596/ https://www.ncbi.nlm.nih.gov/pubmed/31723587 http://dx.doi.org/10.1097/TXD.0000000000000931 |
| _version_ | 1783459006773198848 |
|---|---|
| author | Chedid, Marcio F. Rodrigo, Emilio |
| author_facet | Chedid, Marcio F. Rodrigo, Emilio |
| author_sort | Chedid, Marcio F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6791596 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Wolters Kluwer Health |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-67915962019-11-13 Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? Chedid, Marcio F. Rodrigo, Emilio Transplant Direct Commentary—Invited Wolters Kluwer Health 2019-09-23 /pmc/articles/PMC6791596/ /pubmed/31723587 http://dx.doi.org/10.1097/TXD.0000000000000931 Text en Copyright © 2019 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Commentary—Invited Chedid, Marcio F. Rodrigo, Emilio Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? |
| title | Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? |
| title_full | Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? |
| title_fullStr | Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? |
| title_full_unstemmed | Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? |
| title_short | Bortezomib: A New Promising Therapy for Early Antibody-Mediated Rejection After Liver Transplantation? |
| title_sort | bortezomib: a new promising therapy for early antibody-mediated rejection after liver transplantation? |
| topic | Commentary—Invited |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6791596/ https://www.ncbi.nlm.nih.gov/pubmed/31723587 http://dx.doi.org/10.1097/TXD.0000000000000931 |
| work_keys_str_mv | AT chedidmarciof bortezomibanewpromisingtherapyforearlyantibodymediatedrejectionafterlivertransplantation AT rodrigoemilio bortezomibanewpromisingtherapyforearlyantibodymediatedrejectionafterlivertransplantation |